MedTrace Logo

Role of Nesfatin-1 and Nicotinamide in Infertile Women With Polycystic Ovary Syndrome

NCT03870035 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 56

Last updated 2019-04-26

No results posted yet for this study

Summary

evaluation of the potential role of circulating Nesfatin-1 and Nicotinamide in patients with polycystic ovary syndrome.

and detection the correlation between Nesfatin-1 and body mass index (BMI), Waist hip ratio (WHR), blood glucose, insulin, insulin resistance, lipid profiles, prolactin, LH, FSH, estrogen, progesterone, testosterone and dopamine.

Conditions

  • PCOS

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Hayam G Sayyed, Professor · Assiut University

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2020-04-01
Completion
2020-05-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03870035 on ClinicalTrials.gov